Literature DB >> 32913111

Role of TET1 and 5hmC in an Obesity-Linked Pathway Driving Cancer Stem Cells in Triple-Negative Breast Cancer.

Bin Bao1, Emily A Teslow1, Cristina Mitrea2, Julie L Boerner1, Greg Dyson1, Aliccia Bollig-Fischer3.   

Abstract

Triple-negative breast cancer (TNBC) is a subtype of breast cancer that lacks expression of estrogen receptor, progesterone receptor, and the HER2 but is enriched with cancer stem cell-like cells (CSC). CSCs are the fraction of cancer cells recognized as the source of primary malignant tumors that also give rise to metastatic recurrence. 5-Hydroxymethylcytosine (5hmC) is a DNA epigenetic feature derived from 5-methylcytosine by action of tet methylcytosine dioxygenase enzymes (e.g., TET1); and although TET1 and 5hmC are required to maintain embryonic stem cells, the mechanism and role in CSCs remain unknown. Data presented in this report support the conclusion that TET1 and TET1-dependent 5hmC mediate hydrogen peroxide (H2O2)-dependent activation of a novel gene expression cascade driving self-renewal and expansion of CSCs in TNBC. Evidence presented also supports that the H2O2 affecting this pathway arises due to endogenous mechanisms-including downregulation of antioxidant enzyme catalase in TNBC cells-and by exogenous routes, such as systemic inflammation and oxidative stress coupled with obesity, a known risk factor for TNBC incidence and recurrence. IMPLICATIONS: This study elucidates a pathway dependent on H2O2 and linked to obesity-driven TNBC tumor-initiating CSCs; thus, it provides new understanding that may advance TNBC prevention and treatment strategies. ©2020 American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 32913111      PMCID: PMC7718329          DOI: 10.1158/1541-7786.MCR-20-0359

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  49 in total

Review 1.  Tackling the cancer stem cells - what challenges do they pose?

Authors:  Diwakar R Pattabiraman; Robert A Weinberg
Journal:  Nat Rev Drug Discov       Date:  2014-07       Impact factor: 84.694

2.  Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.

Authors:  Justin D Lathia; Ofer Reizes; Praveena S Thiagarajan; Masahiro Hitomi; James S Hale; Alvaro G Alvarado; Balint Otvos; Maksim Sinyuk; Kevin Stoltz; Andrew Wiechert; Erin Mulkearns-Hubert; Awad Jarrar; Qiao Zheng; Dustin Thomas; Thomas Egelhoff; Jeremy N Rich; Huiping Liu
Journal:  Stem Cells       Date:  2015-05-15       Impact factor: 6.277

3.  Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity.

Authors:  Zachary J Ward; Sara N Bleich; Angie L Cradock; Jessica L Barrett; Catherine M Giles; Chasmine Flax; Michael W Long; Steven L Gortmaker
Journal:  N Engl J Med       Date:  2019-12-19       Impact factor: 91.245

Review 4.  Membrane transport of hydrogen peroxide.

Authors:  Gerd P Bienert; Jan K Schjoerring; Thomas P Jahn
Journal:  Biochim Biophys Acta       Date:  2006-03-10

5.  Mbd3/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells.

Authors:  Ozlem Yildirim; Ruowang Li; Jui-Hung Hung; Poshen B Chen; Xianjun Dong; Ly-Sha Ee; Zhiping Weng; Oliver J Rando; Thomas G Fazzio
Journal:  Cell       Date:  2011-12-23       Impact factor: 41.582

6.  Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience.

Authors:  G Berclaz; S Li; K N Price; A S Coates; M Castiglione-Gertsch; C-M Rudenstam; S B Holmberg; J Lindtner; D Erien; J Collins; R Snyder; B Thürlimann; M F Fey; C Mendiola; I Dudley Werner; E Simoncini; D Crivellari; R D Gelber; A Goldhirsch
Journal:  Ann Oncol       Date:  2004-06       Impact factor: 32.976

7.  TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer.

Authors:  Charly Ryan Good; Shoghag Panjarian; Andrew D Kelly; Jozef Madzo; Bela Patel; Jaroslav Jelinek; Jean-Pierre J Issa
Journal:  Cancer Res       Date:  2018-06-11       Impact factor: 12.701

8.  Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs.

Authors:  S H Ou; F Wu; D Harrich; L F García-Martínez; R B Gaynor
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

9.  Integrating 5hmC and gene expression data to infer regulatory mechanisms.

Authors:  Cristina Mitrea; Priyanga Wijesinghe; Greg Dyson; Adéle Kruger; Douglas M Ruden; Sorin Draghici; Aliccia Bollig-Fischer
Journal:  Bioinformatics       Date:  2018-05-01       Impact factor: 6.931

10.  Exogenous IL-6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells.

Authors:  Emily A Teslow; Bin Bao; Greg Dyson; Christophe Legendre; Cristina Mitrea; Wael Sakr; John D Carpten; Isaac Powell; Aliccia Bollig-Fischer
Journal:  Mol Oncol       Date:  2018-05-24       Impact factor: 6.603

View more
  7 in total

1.  Epigenetic aberrations of gene expression in a rat model of hepatocellular carcinoma.

Authors:  Cayla Boycott; Megan Beetch; Tony Yang; Katarzyna Lubecka; Yuexi Ma; Jiaxi Zhang; Lucinda Kurzava Kendall; Melissa Ullmer; Benjamin S Ramsey; Sandra Torregrosa-Allen; Bennett D Elzey; Abigail Cox; Nadia Atallah Lanman; Alisa Hui; Nathaniel Villanueva; Aline de Conti; Tao Huan; Igor Pogribny; Barbara Stefanska
Journal:  Epigenetics       Date:  2022-05-03       Impact factor: 4.861

Review 2.  Regulation of cancer stem cells in triple negative breast cancer.

Authors:  Norman Fultang; Madhuparna Chakraborty; Bela Peethambaran
Journal:  Cancer Drug Resist       Date:  2021-06-19

3.  TET1 Isoforms Have Distinct Expression Pattern, Localization and Regulation in Breast Cancer.

Authors:  Mahmoud Alzahayqa; Abrar Jamous; Areej A H Khatib; Zaidoun Salah
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

4.  Tracing TET1 expression in prostate cancer: discovery of malignant cells with a distinct oncogenic signature.

Authors:  U Schagdarsurengin; C Luo; H Slanina; D Sheridan; S Füssel; N Böğürcü-Seidel; S Gattenloehner; G B Baretton; L C Hofbauer; F Wagenlehner; T Dansranjav
Journal:  Clin Epigenetics       Date:  2021-11-29       Impact factor: 6.551

5.  Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC.

Authors:  Kousik Kesh; Roberto Mendez; Beatriz Mateo-Victoriano; Vanessa T Garrido; Brittany Durden; Vineet K Gupta; Alfredo Oliveras Reyes; Nipun Merchant; Jashodeep Datta; Santanu Banerjee; Sulagna Banerjee
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 6.  The Roles of DNA Demethylases in Triple-Negative Breast Cancer.

Authors:  Shoghag Panjarian; Jean-Pierre J Issa
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-29

Review 7.  Deoxyribonucleic Acid 5-Hydroxymethylation in Cell-Free Deoxyribonucleic Acid, a Novel Cancer Biomarker in the Era of Precision Medicine.

Authors:  Ling Xu; Yixin Zhou; Lijie Chen; Abdul Saad Bissessur; Jida Chen; Misha Mao; Siwei Ju; Lini Chen; Cong Chen; Zhaoqin Li; Xun Zhang; Fei Chen; Feilin Cao; Linbo Wang; Qinchuan Wang
Journal:  Front Cell Dev Biol       Date:  2021-12-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.